RPE65 Retinitis Pigmentosa Can Start Early and Still Vary Sharply in Severity
A small multicenter Japanese series is adding detail to a disease that is already familiar to retinal specialists but still clinically unpredictable. In nine genetically confirmed patients with RPE65-related retinitis pigmentosa, the visual course ranged from early childhood onset to a rarer adult-onset presentation, with substantial variation in how quickly central vision and field function collapsed.
Most patients first developed symptoms between ages 2 and 7 years. One patient presented later, as an adult. No patient had nystagmus, a finding that may seem subtle on paper but matters in clinic because it can delay suspicion of severe inherited retinal disease when the exam is otherwise quiet early in life.
The cohort came from four Japanese institutions and included seven unrelated individuals plus one sibling pair. Retrospective chart review captured the usual tools of inherited retinal dystrophy care: best-corrected visual acuity, fundus photography, autofluorescence imaging, optical coherence tomography, Goldmann perimetry, and electroretinography. The clinical picture that emerged was not one of uniform decline. It was a spectrum, and the range itself is the story.
Central Vision Often Survived Childhood Before Falling Away
Five patients reached 20/40 vision or better at some point, either by historical report or by measurement. That apparent reserve can be misleading. Seven patients eventually fell to 20/250 or worse in at least one eye, showing how a child who still reads well enough for school can later lose the central acuity needed for navigation, facial recognition, and independent daily activity.
The retinal imaging and functional testing fit the diagnosis of progressive rod-cone dystrophy. All patients showed retinal degeneration consistent with RP, and every electroretinogram was non-detectable. In practice, that means the retina had already lost measurable electrical responsiveness by the time these patients were evaluated, even if some still retained a usable central island of vision.
Retinitis pigmentosa from RPE65 mutations is biologically plausible as an aggressive phenotype because the gene is tied to the visual cycle. When the cycle falters, chromophore regeneration becomes inefficient, photoreceptors are stressed, and degeneration advances. The phenotype in this cohort matched that mechanism: early functional disturbance, then structural loss, then a broad field constriction that eventually encroached on central function.
Two Variants Stood Out With Better Residual Structure
Within the small series, two patients carrying compound heterozygous variants — c.1543C > T (p.Arg515Trp) and c.683A > C (p.Gln228Pro) — retained better vision and had a wider residual ellipsoid zone and visual field. This is the kind of genotype-phenotype signal retinal clinicians look for, because ellipsoid zone width on OCT serves as a structural proxy for surviving photoreceptors.
The structural difference was not cosmetic. A wider residual ellipsoid zone suggests more viable outer retinal architecture, and in inherited retinal disease that often tracks with better retained function. The wider Goldmann field in those patients reinforces the same point from a different angle: enough photoreceptor integrity remained to preserve a larger usable visual area, at least for longer than in the rest of the cohort.
One sentence captures the clinical weight of the finding: genotype did not predict a single uniform course, but it did separate a subgroup with more persistent retinal structure.
Severe Handicaps Arrived by Early Adulthood in Many Cases
The adult consequences were sobering. Severe visual handicap emerged by early adulthood in many patients, even in a disorder that had begun years earlier in childhood. That trajectory has real consequences for education, employment, mobility, and family planning, especially when the child appears to function relatively well before the field loss and acuity loss become irreversible in daily life.
Goldmann perimetry and OCT helped expose the hidden progression. A shrinking visual field can be missed if attention focuses only on acuity, and RP often punishes that blind spot in clinical surveillance. Central acuity may remain acceptable long after peripheral navigation has become fragile. Then the center follows.
The lack of detectable electroretinogram responses across the cohort also makes one practical point: by the time many patients enter specialty care, the window for preserving large areas of function may already be narrow. That does not make genetic diagnosis less valuable. It makes it more urgent.
Why This Rare-Disease Series Matters Beyond Nine Patients
Small inherited retinal disease series often look modest in scale, yet they can still shape clinical expectations. Here, the main contribution is not a new treatment effect or a survival comparison. It is a clearer portrait of RPE65-RP as a disorder that can begin in early childhood, preserve enough vision to delay alarm, and then progress to major functional impairment before mid-adulthood in many cases.
For clinicians, the message is straightforward. A child with early nyctalopia or peripheral field complaints may have a far more advanced retinal disorder than the acuity number suggests. Normal-looking central function in the exam room does not exclude progressive photoreceptor loss, especially when OCT reveals ellipsoid zone shortening and perimetry is already constricted.
For families, the variability cuts both ways. Some patients preserve more structure and function than others, and the two compound heterozygous cases in this report illustrate that point. Yet the overall trajectory in the broader cohort remained severe enough to produce marked disability early in adult life.
The report also arrives at a time when RPE65-associated retinal disease is especially relevant to genetic counseling and therapeutic planning. Precise molecular diagnosis can separate patients with different expected courses and can anchor decisions about follow-up intensity, visual rehabilitation, and candidacy for emerging interventions. The value of such a diagnosis is not abstract; it determines how aggressively a retina clinic watches the clock on usable vision.
Genotype-Phenotype Correlation Still Needs Broader Confirmation
Nine patients cannot define the full natural history of the disease, and the series itself makes that obvious. The strongest signals came from careful phenotyping rather than sample size. Early childhood onset dominated, nystagmus was absent, central vision could remain deceptively good for a time, and severe loss still accumulated by early adulthood in many cases.
Those observations are useful precisely because they are granular. They give clinicians something to compare with their own patients instead of a generic diagnosis label. They also suggest that variant-specific residual structure may matter, especially when monitoring OCT ellipsoid zone preservation and visual field extent over time.
The unanswered practical issue is how best to use this variability at the bedside. The cohort makes clear that RPE65-related RP is not clinically flat. It behaves as a heterogeneous inherited retinal dystrophy in which genotype, retinal structure, and functional reserve can part ways for years before converging on major visual loss.